Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow

NCT07223307 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT07223307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of REal Time MRI GUided Adaptive Stereotactic Ablative Radiotherapy for Liver Cancers Using a Single Session, Simulation Free Workflow
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Recruiting
Start date
January 23, 2026
Completion date
January 31, 2030
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, intrahepatic cholangiocarcinoma, liver cancer, liver metastases